Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTLI.L Regulatory News (TLI)

  • There is currently no data for TLI

Interim Management Statement

3 May 2012 16:36

RNS Number : 7075C
Alternative Asset Opps PCC Ltd
03 May 2012
 



 

 

3 May 2012

Alternative Asset Opportunities PCC Limited

(the "Company")

Interim Management Statement

 

This interim management statement relates to the period from 1 January 2012 to the date of publication of this statement and has been prepared solely to provide additional information in order to meet the relevant requirement of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by shareholders, or any other party, for any other purpose.

 

The Company is a closed-ended Guernsey registered protected cell company with one cell known as the US Traded Life Interests Fund (the "Fund").

 

Investment objective

The Company's investment objective in respect of the Fund is to provide investors with an attractive capital return through investment predominantly in a diversified portfolio of US Traded Life Interests ("TLIs").

 

Financial position and performance

Over the period to 31 March 2012, the Company's net asset value per share decreased by 6.7% to 70.5 pence. As at 31 March 2012, the shares were trading at a 44.7% discount to net asset value.

 

Two policy maturities on two lives were identified during the period, and policy maturity proceeds were received during March/April 2012 adding circa 0.9 pence to the NAV per share. There have been, in aggregate, 34 policy maturities since the Fund's inception.

 

The Company's loan agreement with Allied Irish Banks plc ("AIB") was renewed to cover the necessary funding up to 28 September 2012. As at 31 March 2012, total borrowings under the agreement amounted to US$27,510,000 after settlement of the foreign exchange positions as at that date.

 

As previously announced, the Board intends to dispose of some policies as and when suitable opportunities arise. To date, sale contracts have been exchanged with three counterparties for the sale of 12 policies, which have realised US$10.7 million. The Board is pleased to report that this has been achieved without any significant impact on the net asset value per share. A further batch of policies is currently being reviewed for possible sale.

 

The Board is not aware of any other material events during the period from 1 January 2012 to 31 March 2012, or in the period from 1 April 2012 to the date of this announcement which would have had a material impact on the financial position of the Company.

 

As in recent reports, the illustrative 'Sensitivity Matrix' set out below, is expressed in terms of NAV per share and enables the Board to show the effect of differing market IRR assumptions.

- The first line of NAVs in the table uses the 'Latest LE' assumption, that is to say either an LE based on a recently updated assessment or, for the remaining 22% of the portfolio by face value (the 'non-updated policies'), based on the original LE assessed at the time of purchase. The average LE (weighted by policy value) is shown for reference (4.6 years). NAV is then shown at four different discount rates, ranging from 10% to 20%. This shows the effect of IRR on current value, but it also allows investors to assess the effects of forced sales if, for example, the portfolio was to be liquidated before 31 December 2016.

 

- The second line uses the assumption that updated LEs obtained for the non-updated polices would broadly follow those already obtained for other policies, resulting in an LE increase of 20% on the non-updated policies. In practice, the LE changes exhibited by actual revised assessments vary widely and the Board does not feel it is necessarily correct to extrapolate the changes for the non-updated policies. The overall effect is to increase average LE by 0.12 years.

 

- The third line assumes an increase in LE of 40% on the non-updated policies. The effect on NAV is roughly proportionate to that shown in the second line, but the increase in LE is only 0.04 years because of the fact that policies are weighted by value - such an extension to LE of course has significant impact on the values of some of these policies.

 

- Finally, the fourth line shows the outcome of assuming LEs are simply based on the current table of life expectancies for the general population, the 2008 Valuation Basic Table (Ultimate), i.e. ignoring LE assessments. The Board does not suggest that this is a realistic assumption, but it gives a measure of the degree to which the portfolio is dependent on assessed LEs being shorter than for the population as a whole.

 

 

Sensitivity Matrix

Net Asset Value in pence per share on various assumptions as at 31 March 2012

 

Mortality Assumptions

Weighted Average LE*

Discount Rates applied to cash flows

10%

Current (12%)

16%

20%

Latest LE

4.6

77.8

70.5

58.3

48.5

+20% for LE dates before 01/11/2008

4.7

71.9

64.7

52.8

43.4

+40% for LE dates before 01/11/2008

4.8

67.8

60.8

49.2

40.1

No underwriting

5.5

58.3

50.9

39.1

29.7

 

* The weighted average LE (in years) is calculated by reference to the policy values obtained.

 

 

Source: SL Investment Management Limited

 

 

 

Top ten holdings

By reference to the most recent portfolio valuation of the Company as at 31 March 2012, the largest ten investments held by the Company, measured by life office exposure, were as follows:

 

Issuer

Number of policies

% of totalassets as at31 March 2012

American General Life Insurance Company (TX)

13

21.06%

Lincoln National Life Insurance Co

14

15.88%

Transamerica Life Insurance Company

19

13.86%

Massachusetts Mutual Life Insurance Co

8

8.25%

John Hancock Life Insurance Company

10

7.78%

MetLife Insurance Company of Connecticut

6

3.99%

Security Life of Denver Insurance Co

1

3.98%

Aviva Life and Annuity Company

4

3.71%

New York Life Insurance and Annuity Corp

5

3.18%

National Western Life Insurance Company

1

2.92%

 

 

Company Information

 

Launch date 25 March 2004

EPIC TLI

Year end 30 June

Report & Accounts Annual Report posted October, Interim posted February

AGM November

Price Information Financial Times (under INVESTMENT COMPANIES, listed as 'AltAstsOpps.')

 

Investor Information

 

Further portfolio information, including the latest available factsheets, is provided on the Manager's website and can be accessed via http://www.rcm.com/investmenttrusts/investors_tlif.php (under the Professional Investors section).

 

 

By order of the Board

Alternative Asset Opportunities PCC Limited

 

Enquiries:

Peter Ingram

Company Secretary Tel: 020 7065 1467

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGUPWAUPPGAW
Date   Source Headline
8th Dec 201612:38 pmRNSShareholder Update
5th Dec 201612:09 pmRNSListing Rule 15.6.8
29th Nov 201611:11 amRNSShareholder Update
22nd Nov 20162:35 pmRNSShareholder Update
17th Nov 201610:23 amRNSNet Asset Value and Shareholder Update
8th Nov 20163:13 pmRNSProposals for Voluntary Liquidation and EGM
2nd Nov 20164:33 pmRNSListing Rule 15.6.8
2nd Nov 201611:12 amRNSShareholder Update
2nd Nov 20169:42 amRNSHolding(s) in Company
26th Oct 201610:30 amRNSShareholder Update
25th Oct 20163:29 pmRNSHolding(s) in Company
20th Oct 20161:52 pmRNSNet Asset Value(s)
14th Oct 20163:39 pmRNSFinal Results
13th Oct 20161:54 pmRNSShareholder Update
10th Oct 20161:35 pmRNSResult of Meeting
4th Oct 20169:49 amRNSListing Rule 15.6.8
3rd Oct 20165:17 pmRNSPolicy Maturity
26th Sep 20161:33 pmRNSProposed disposal of portfolio - Update
16th Sep 20162:08 pmRNSNet Asset Value(s)
13th Sep 201612:49 pmRNSPublication and Submission of Circular to NSM
13th Sep 20167:00 amRNSChange of Investment Policy and Objective
6th Sep 201611:50 amRNSListing Rule 15.6.8
31st Aug 20167:00 amRNSDoc re. Policy Maturity
17th Aug 201610:16 amRNSNet Asset Value(s)
3rd Aug 20165:23 pmRNSListing Rule 15.6.8
15th Jul 20164:58 pmRNSNet Asset Value(s)
4th Jul 201611:49 amRNSListing Rule 15.6.8
23rd Jun 201612:37 pmRNSShareholder Update
16th Jun 20163:13 pmRNSNet Asset Value(s)
2nd Jun 20164:25 pmRNSListing Rule 15.6.8
26th May 20168:47 amRNSCost of Insurance
16th May 20165:07 pmRNSNet Asset Value(s)
11th May 20163:56 pmRNSPotential increase in the Cost of Insurance
4th May 201610:31 amRNSListing Rule 15.6.8
19th Apr 20168:46 amRNSNet Asset Value(s)
12th Apr 201612:40 pmRNSHolding(s) in Company
4th Apr 20163:31 pmRNSListing Rule 15.6.8
23rd Mar 20165:36 pmRNSHalf Yearly Report
15th Mar 201611:09 amRNSNet Asset Value(s)
8th Mar 20167:00 amRNSHalf Yearly Report
2nd Mar 201612:40 pmRNSListing Rule 15.6.8
1st Mar 201610:27 amRNSHolding(s) in Company
24th Feb 20164:16 pmRNSHome Member State - DTR 6.4.2
22nd Feb 20164:12 pmRNSPolicy Maturity
17th Feb 20167:00 amRNSNet Asset Value(s)
2nd Feb 20162:06 pmRNSListing Rule 15.6.8
18th Jan 20169:43 amRNSNet Asset Value(s)
5th Jan 20163:21 pmRNSListing Rule 15.6.8
4th Jan 20168:47 amRNSCompliance with Model Code
16th Dec 201512:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.